Galaxy Surfactants (NSE: GALAXYSURF) Q3 FY26 results signal portfolio resilience as specialty growth offsets global surfactant pressures
Natural Capsules (NSE: NATCAPSUQ) Q3 FY26 results signal operational recovery after regulatory shock, but fermentation execution risk still looms
Read More 7 minute read Healthcare Industry News Inside Galderma’s blockbuster Q3: Why EQT cashed out CHF690m amid record dermatology growth Find out why EQT exited CHF 690 million in Galderma shares as the dermatology major raised full-year growth guidance after strong Q3 results. bySrinathOctober 31, 2025